DE59407494D1 - 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel - Google Patents
4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittelInfo
- Publication number
- DE59407494D1 DE59407494D1 DE59407494T DE59407494T DE59407494D1 DE 59407494 D1 DE59407494 D1 DE 59407494D1 DE 59407494 T DE59407494 T DE 59407494T DE 59407494 T DE59407494 T DE 59407494T DE 59407494 D1 DE59407494 D1 DE 59407494D1
- Authority
- DE
- Germany
- Prior art keywords
- stands
- atom
- compounds
- hydrogen
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- NUKYPUAOHBNCPY-UHFFFAOYSA-N 4-aminopyridine Chemical compound NC1=CC=NC=C1 NUKYPUAOHBNCPY-UHFFFAOYSA-N 0.000 title 1
- 229960004979 fampridine Drugs 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 150000003928 4-aminopyridines Chemical class 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE59407494T DE59407494D1 (de) | 1993-03-03 | 1994-03-02 | 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4306506A DE4306506A1 (de) | 1993-03-03 | 1993-03-03 | Neue 4-Alkylaminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| DE19934312966 DE4312966A1 (de) | 1993-04-21 | 1993-04-21 | Neue 4-Aminopyridine - Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| DE59407494T DE59407494D1 (de) | 1993-03-03 | 1994-03-02 | 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
| PCT/EP1994/000608 WO1994020467A1 (de) | 1993-03-03 | 1994-03-02 | Neue 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE59407494D1 true DE59407494D1 (de) | 1999-01-28 |
Family
ID=25923593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE59407494T Expired - Fee Related DE59407494D1 (de) | 1993-03-03 | 1994-03-02 | 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0687253B1 (OSRAM) |
| JP (1) | JPH08507503A (OSRAM) |
| KR (1) | KR100252551B1 (OSRAM) |
| CN (1) | CN1046710C (OSRAM) |
| AT (1) | ATE174590T1 (OSRAM) |
| AU (1) | AU682026B2 (OSRAM) |
| CA (1) | CA2156729A1 (OSRAM) |
| CZ (1) | CZ225495A3 (OSRAM) |
| DE (1) | DE59407494D1 (OSRAM) |
| DK (1) | DK0687253T3 (OSRAM) |
| ES (1) | ES2127919T3 (OSRAM) |
| FI (1) | FI954105A7 (OSRAM) |
| GR (1) | GR3029691T3 (OSRAM) |
| HU (1) | HUT72898A (OSRAM) |
| IL (1) | IL108786A (OSRAM) |
| NO (1) | NO953447L (OSRAM) |
| NZ (1) | NZ262725A (OSRAM) |
| PL (1) | PL176455B1 (OSRAM) |
| RU (1) | RU2126388C1 (OSRAM) |
| SK (1) | SK108295A3 (OSRAM) |
| TW (1) | TW257757B (OSRAM) |
| WO (1) | WO1994020467A1 (OSRAM) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4430755A1 (de) * | 1994-08-30 | 1996-03-07 | Boehringer Mannheim Gmbh | Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US5792769A (en) * | 1995-09-29 | 1998-08-11 | 3-Dimensional Pharmaceuticals, Inc. | Guanidino protease inhibitors |
| GB9525620D0 (en) | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
| CA2256309C (en) | 1995-12-29 | 2006-08-15 | 3-Dimensional Pharmaceuticals, Inc. | Amidino protease inhibitors |
| GB9602166D0 (en) | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
| AU1608397A (en) | 1996-02-02 | 1997-08-22 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| SE9602646D0 (sv) * | 1996-07-04 | 1996-07-04 | Astra Ab | Pharmaceutically-useful compounds |
| IL128428A0 (en) * | 1996-08-14 | 2000-01-31 | Zeneca Ltd | Substituted pyrimidine derivatives and their pharmaceutical use |
| JP2001500864A (ja) * | 1996-09-13 | 2001-01-23 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害物質 |
| GB9821483D0 (en) | 1998-10-03 | 1998-11-25 | Glaxo Group Ltd | Chemical compounds |
| UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| TW499412B (en) | 1996-11-26 | 2002-08-21 | Dimensional Pharm Inc | Aminoguanidines and alkoxyguanidines as protease inhibitors |
| AU7624298A (en) * | 1996-12-03 | 1998-06-29 | Graybill, Todd L. | Aminobenzenedicarboxylic acid-based combinatorial libraries |
| US6391880B1 (en) | 1997-02-13 | 2002-05-21 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| WO1998035956A1 (en) | 1997-02-13 | 1998-08-20 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| JP4327915B2 (ja) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | スルフォンアミド誘導体 |
| IL141992A0 (en) | 1998-10-06 | 2002-03-10 | Dainippon Pharmaceutical Co | 2,3-disubstituted pyridine derivative, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
| GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| AR023510A1 (es) | 1999-04-21 | 2002-09-04 | Astrazeneca Ab | Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina. |
| JP2004505956A (ja) | 2000-08-04 | 2004-02-26 | ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド | 環式オキシグアニジンプロテアーゼインヒビター |
| PL206094B1 (pl) * | 2000-10-04 | 2010-06-30 | Kissei Pharmaceutical | Pochodne 5-amidyno-2- hydroksybenzenosulfonamidu, zawierająca je kompozycja farmaceutyczna oraz zastosowanie takiej pochodnej |
| JP2004535390A (ja) * | 2001-05-07 | 2004-11-25 | スミスクライン・ビーチャム・コーポレイション | スルホンアミド |
| WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| DE60322544D1 (de) | 2002-08-27 | 2008-09-11 | Merck Patent Gmbh | Glycinamid-derivate als raf-kinase-hemmer |
| JP2006508061A (ja) * | 2002-09-20 | 2006-03-09 | ファイザー・プロダクツ・インク | エストロゲン受容体に対するアミドおよびスルホンアミドリガンド |
| NZ546444A (en) | 2003-11-05 | 2009-09-25 | Hoffmann La Roche | Phenyl derivatives as PPAR agonists |
| CN101622231B (zh) * | 2007-02-28 | 2013-12-04 | 艾德维纳斯医疗私人有限公司 | 作为葡糖激酶激活剂的2，2，2-三取代的乙酰胺衍生物、它们的制造方法和药学应用 |
| RU2353619C2 (ru) * | 2007-06-28 | 2009-04-27 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией антикоагулянтов, фармацевтические композиции на их основе для лечения тромботических состояний и плазмозамещающий раствор для коррекции гиперкоагуляционных нарушений при гемодилюции |
| RU2354647C2 (ru) * | 2007-06-28 | 2009-05-10 | Общество С Ограниченной Ответственностью "Бионика" | Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| US8265575B2 (en) * | 2009-06-16 | 2012-09-11 | Mediatek Inc. | Methods for handling a transmitting process and communication apparatuses utilizing the same |
| US8207639B2 (en) | 2009-10-23 | 2012-06-26 | Sunonwealth Electric Machine Industry Co., Ltd. | Motor and heating dissipating fan including motor having an annular balancing member |
| RU2685261C1 (ru) * | 2018-04-05 | 2019-04-17 | Общество с ограниченной ответственностью "ФК ЛАБОРАТОРИЗ" | Вещество 4-амино-1-{ 2-[3-метил-5-(бензолсульфонилокси)фенокси] этил} -пиридиний хлорид, обладающее свойствами биологически активного агента, влияющими на естественно текущие процессы свертываемости крови млекопитающих, антикоагулянт на его основе и способ его получения путем химического синтеза |
| CN109172573B (zh) * | 2018-09-12 | 2021-01-26 | 黑龙江中桂制药有限公司 | 一种口服抗血栓药物及其用途 |
| CN110669337B (zh) * | 2019-07-08 | 2020-09-25 | 中国科学院长春应用化学研究所 | 一种芳香型二胺单体及其制备方法 |
| WO2024243343A2 (en) * | 2023-05-23 | 2024-11-28 | John Karanicolas | Compounds that re-activate mutant p53 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1097620A1 (ru) * | 1983-02-16 | 1984-06-15 | Новокузнецкий научно-исследовательский химико-фармацевтический институт | Способ получени диэтил-N-(6-метилпиридил-2)-аминометиленмалоната |
| SU1318599A1 (ru) * | 1985-06-26 | 1987-06-23 | МГУ им.М.В.Ломоносова | Способ получени 1-алкил-2-хлор-2-алкоксиэтенилалкил(арил)хлорфосфинов |
| DE3529529A1 (de) * | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| GB8819307D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Antiarrhythmic agents |
| JPH0256465A (ja) * | 1988-08-22 | 1990-02-26 | Hamari Yakuhin Kogyo Kk | アセトアミド化合物 |
| US4885927A (en) * | 1988-09-12 | 1989-12-12 | General Motors Corporation | Method and apparatus for press forming intricate metallic shapes such as spool valve elements |
| JPH07501057A (ja) * | 1991-10-31 | 1995-02-02 | スミスクライン・ビーチャム・コーポレイション | フィブリノーゲン・アンタゴニスト用ｃ８−環状ペプチド模倣体 |
| TW221996B (OSRAM) * | 1991-11-14 | 1994-04-01 | Glaxo Group Ltd | |
| DE4212304A1 (de) * | 1992-04-13 | 1993-10-14 | Cassella Ag | Asparaginsäurederivate, ihre Herstellung und Verwendung |
-
1994
- 1994-02-22 TW TW083101504A patent/TW257757B/zh active
- 1994-02-28 IL IL10878694A patent/IL108786A/en not_active IP Right Cessation
- 1994-03-02 DK DK94909909T patent/DK0687253T3/da active
- 1994-03-02 AT AT94909909T patent/ATE174590T1/de not_active IP Right Cessation
- 1994-03-02 JP JP6519556A patent/JPH08507503A/ja active Pending
- 1994-03-02 WO PCT/EP1994/000608 patent/WO1994020467A1/de not_active Application Discontinuation
- 1994-03-02 CA CA002156729A patent/CA2156729A1/en not_active Abandoned
- 1994-03-02 CZ CZ952254A patent/CZ225495A3/cs unknown
- 1994-03-02 FI FI954105A patent/FI954105A7/fi unknown
- 1994-03-02 KR KR1019950703694A patent/KR100252551B1/ko not_active Expired - Fee Related
- 1994-03-02 ES ES94909909T patent/ES2127919T3/es not_active Expired - Lifetime
- 1994-03-02 HU HU9502568A patent/HUT72898A/hu unknown
- 1994-03-02 SK SK1082-95A patent/SK108295A3/sk unknown
- 1994-03-02 AU AU62574/94A patent/AU682026B2/en not_active Ceased
- 1994-03-02 NZ NZ262725A patent/NZ262725A/en unknown
- 1994-03-02 EP EP94909909A patent/EP0687253B1/de not_active Expired - Lifetime
- 1994-03-02 RU RU95122612A patent/RU2126388C1/ru active
- 1994-03-02 PL PL94310520A patent/PL176455B1/pl unknown
- 1994-03-02 CN CN94191554A patent/CN1046710C/zh not_active Expired - Fee Related
- 1994-03-02 DE DE59407494T patent/DE59407494D1/de not_active Expired - Fee Related
-
1995
- 1995-09-01 NO NO953447A patent/NO953447L/no unknown
-
1999
- 1999-03-16 GR GR990400775T patent/GR3029691T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL310520A1 (en) | 1995-12-27 |
| FI954105A0 (fi) | 1995-09-01 |
| FI954105A7 (fi) | 1995-09-01 |
| ATE174590T1 (de) | 1999-01-15 |
| IL108786A0 (en) | 1994-06-24 |
| EP0687253B1 (de) | 1998-12-16 |
| HU9502568D0 (en) | 1995-11-28 |
| AU682026B2 (en) | 1997-09-18 |
| JPH08507503A (ja) | 1996-08-13 |
| GR3029691T3 (en) | 1999-06-30 |
| CA2156729A1 (en) | 1994-09-15 |
| SK108295A3 (en) | 1996-06-05 |
| WO1994020467A1 (de) | 1994-09-15 |
| AU6257494A (en) | 1994-09-26 |
| CN1046710C (zh) | 1999-11-24 |
| NO953447D0 (no) | 1995-09-01 |
| ES2127919T3 (es) | 1999-05-01 |
| NO953447L (no) | 1995-09-01 |
| CZ225495A3 (en) | 1996-01-17 |
| DK0687253T3 (da) | 1999-08-23 |
| HUT72898A (en) | 1996-06-28 |
| RU2126388C1 (ru) | 1999-02-20 |
| IL108786A (en) | 1999-04-11 |
| CN1119858A (zh) | 1996-04-03 |
| PL176455B1 (pl) | 1999-05-31 |
| KR100252551B1 (ko) | 2000-05-01 |
| TW257757B (OSRAM) | 1995-09-21 |
| NZ262725A (en) | 1997-05-26 |
| EP0687253A1 (de) | 1995-12-20 |
| KR960701019A (ko) | 1996-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE59407494D1 (de) | 4-aminopyridine, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
| ATE124047T1 (de) | Oxazolopyridinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen. | |
| ATE128458T1 (de) | Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE40368T1 (de) | Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE289996T1 (de) | Arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| ATE127452T1 (de) | Poly-4-aminopyrrole-2-carboxamide derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ATE174920T1 (de) | Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE3869173D1 (de) | Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ATE74352T1 (de) | Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| ATE173260T1 (de) | 1,7-anellierte 3-(piperazino-alkyl)indol-derivate sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE16478T1 (de) | 1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| ATE172976T1 (de) | 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE214051T1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| ATE116647T1 (de) | Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE121405T1 (de) | Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| AU639154B2 (en) | New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them | |
| ATE140693T1 (de) | Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE139532T1 (de) | Neue dna-gyrase inhibitoren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE60220779D1 (de) | Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
| DE68905363D1 (de) | Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
| DE58902884D1 (de) | Thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| ATE140216T1 (de) | (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE3860117D1 (de) | 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| ZA909557B (en) | Substituted benzothiazolinones,process for preparing these and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE |
|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |